David M. Charytan, MD, an internationally renowned clinician and researcher in the field of cardio-renal disease, recently joined the Department of Medicine at NYU Langone Health as director of the Division of Nephrology.

Dr. Charytan joins NYU Langone Health from Brigham and Women’s Hospital, where he most recently served as a physician in its Renal Division, and Director of ICU Nephrology. He also held the position of associate professor of medicine at Harvard Medical School and served as director of renal research at the Baim Institute for Clinical Research, an affiliate of Harvard and its five teaching hospitals.

“We are thrilled to welcome Dr. Charytan back to NYU Langone to lead the division of Nephrology,” says Steven B. Abramson, MD, the Frederick H. King Professor of Internal Medicine and chair of the Department of Medicine, and Vice Dean for Education, Faculty, and Academic Affairs. “His clinical and investigative experience will continue to elevate our already outstanding Division of Nephrology, which is recognized for its exceptional academic and clinical expertise.”

In addition to his clinical responsibilities, Dr. Charytan oversees the division’s research, including his own ongoing studies examining the connections between chronic kidney disease and heart disease, the leading cause of death in people with kidney failure. His particular focus is on arrhythmia in dialysis patients and investigating new therapies to minimize the risk of cardiovascular events for people with end-stage kidney failure. 

About Dr. Charytan

An alumnus of NYU School of Medicine, Dr. Charytan completed an internal medicine residency and clinical and research fellowships in nephrology, all at Beth Israel Deaconess Medical Center. He then joined Brigham and Women’s Hospital as a research fellow in nephrology and biometrics. Dr. Charytan also earned a Master of Science degree in epidemiology from Harvard School of Public Health.

Dr. Charytan has published dozens of peer-reviewed articles and presents at national and international meetings. He currently serves as associate editor of the Clinical Journal of the American Society of Nephrology, as well as on committees of several prominent randomized clinical trials.

“My father is a nephrologist, and my mother and aunt both had kidney transplants, so I’m deeply rooted in the field and committed to providing the most comprehensive, cutting-edge care here at NYU Langone Health,” Dr. Charytan says. “I look forward to strengthening our multidisciplinary clinical efforts across the institution and building on already strong efforts to bring research findings to the bedside.”